FPHPE treatment markedly enhanced the cleavage of caspase‐3 and its downstream substrate PARP, while also elevating the Bax/Bcl‐2 ratio in both HCC cell lines and tumor tissues (Figure 4C–E). The gene discussed is BCL2; the disease is neoplasm.